Allurion Technologies ALUR shares are moving higher ... maintaining or even increasing muscle mass. Dr. Shantanu Gaur, CEO of Allurion, stated that the planned study aims to confirm whether ...

The CEO of Allurion, Dr. Shantanu Gaur ... in obesity care if the study confirms the preliminary findings. Allurion Technologies is focused on ending obesity through its innovative weight-loss ...

January 23, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. ("Allurion" or ... weight loss," said Dr. Shantanu Gaur, Founder and CEO of Allurion. "The goal of our study would be to prove ...

Shares of Allurion Technologies (NYSE: ALUR) skyrocketed by 350% following the company's announcement of its plans to initiate a clinical study aimed at optimizing muscle mass during GLP-1 therapy in ...

Allurion Technologies, Inc. (NYSE ... Shantanu Gaur, Allurion's Founder and CEO, expressed confidence in the company's growing patent collection, emphasizing its role in supporting the company's ...

Allurion Technologies (ALUR ... Shantanu Gaur, Allurion’s Founder and CEO, noted, “Our new patent enhances our already robust, global patent portfolio. With it, we now have amassed 20 issued ...

January 21, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. ("Allurion" or ... 1 Shantanu Gaur, Allurion’s Founder and CEO, noted, "Our new patent enhances our already robust, global patent ...

Founder and CEO Dr. Shantanu Gaur explained that decline ... The news has given Allurion Technologies investors something to cheer about after they watched the shares sink rapidly since they ...

Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to initiate a clinical study on the combination of the ...